Grass pollen allergy immunotherapy - Stallergenes Greer plc

Drug Profile

Grass pollen allergy immunotherapy - Stallergenes Greer plc

Alternative Names: 300 IR; 300 IR grass pollen allergen extract - Stallergenes; 300 IR SLIT; Five-grass pollen immunotherapy - Stallergenes; Oralair; Oralair Grasses

Latest Information Update: 01 Jun 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Stallergenes SA
  • Developer Endo International; Stallergenes Greer plc
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Seasonal allergic rhinitis

Most Recent Events

  • 31 May 2017 No recent reports on development identified - Registered for Seasonal allergic rhinitis in Argentina (Sublingual)
  • 03 Mar 2017 Adverse events data from the phase III VO53.06 trial in Seasonal allergic rhinitis presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2017)
  • 05 Mar 2016 Interim efficacy and adverse events data from multiple trials in Seasonal allergic rhinitis presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI - 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top